MYCOF (MYCOF) Stock Price & Analysis
MYCOF (MYCOF) rose 0.00% to USD 0.8 as of July 25, 2026 at 13:51 UTC, according to Nexqual real-time market data.
MYCOF last closed at USD 0.8; the session ranged USD 0.8–0.8 on volume of 1,000 shares. Market capitalization is $46.84M, with a 52-week range of USD 0.03–2.04 (PNK). Source: Nexqual, July 25, 2026 at 13:51 UTC.
Key Statistics (as of July 25, 2026 at 13:51 UTC)
| Price | USD 0.8 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.8 |
| Open | USD 0.8 |
| Day Range | USD 0.8 – 0.8 |
| 52-Week Range | USD 0.03 – 2.04 |
| Volume | 1,000 shares |
| Market Cap | $46.84M |
| Exchange | PNK |
Technical Analysis (MYCOF)
Nexqual's technical model rates MYCOF "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 13:51 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 1.48) |
| MACD | -0.24 (negative) |
Analyst Ratings (MYCOF)
Wall Street analysts rate MYCOF "None", per Nexqual as of July 25, 2026 at 13:51 UTC.
| Consensus Rating | None |
|---|
Earnings (MYCOF)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2022-03-31 | USD -50.38 vs est -50 ▼ miss |
| 2021-12-31 | USD -51.75 vs est -50 ▼ miss |
| 2021-09-30 | USD -43.5 vs est -25 ▼ miss |
Source: Nexqual, July 25, 2026 at 13:51 UTC.
Financials & Fundamentals (MYCOF)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.47 |
| Total Cash | $2.03M |
| Total Debt | $424,269 |
| Free Cash Flow | $-4.67M |
Source: Nexqual, July 25, 2026 at 13:51 UTC.
Financial Health Score (MYCOF)
Nexqual rates MYCOF's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 13:51 UTC.
| Growth | Critical — Revenue -87% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $2M cash, no debt |
| Cash Flow | Weak — FCF negative: -$5M, burning cash |
| Efficiency | Mixed — No data |
Ownership (MYCOF)
| Insider Ownership | +0.05% |
|---|---|
| Institutional Ownership | +6.57% |
| Shares Outstanding | 58.55M |
| Float | 58.52M |
Source: Nexqual, July 25, 2026 at 13:51 UTC.
Leadership (MYCOF)
MYCOF is led by William Cook, Interim CEO & Technical Director of Mindleap Health Inc., per Nexqual as of July 25, 2026 at 13:51 UTC.
| Interim CEO & Technical Director of Mindleap Health Inc. | William Cook |
|---|---|
| CFO & Corporate Secretary | John Charles Ross CA (age 67) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RVVTF | Revive Therapeutics Ltd. | USD 0.02 | ▼ 14.29% |
| HAVLF | HAVN LIFE SCIENCES INC. | USD 0 | ▲ 0% |
| TRUFF | Red Light Holland Corp. | USD 0.02 | ▼ 8.33% |
| EHVVF | Ehave Inc. | USD 0 | ▼ 35.71% |
| HELP | Cybin Inc. | USD 7.62 | ▼ 2.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 13:51 UTC. This page is informational and not investment advice.